Discontinued — last reported Q4 '25

Other

Cashless Exercise Of The Company Common Stock Warrants

This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ3 2022
Last reportedQ4 2025May 20, 2026

How to read this metric

High levels of cashless exercise indicate dilution of existing shareholders without providing new cash capital to the company.

Detailed definition

A non-cash transaction where warrant holders exchange their warrants for common stock without a cash payment to the comp...

Peer comparison

Common in biotech and tech sectors; often disclosed in the non-cash activity section of the cash flow statement.

Metric ID: other_cashless_exercise_of_the_company_common_stock_warrants

Historical Data

12 periods
 Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00-$20.81M-$20.81M-$20.81M-$20.81M$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change+0.0%+0.0%+0.0%+100.0%
YoY Change+100.0%+100.0%
Range-$20.81M$0.00
Avg YoY Growth+100.0%
Median YoY Growth+100.0%

Frequently Asked Questions

What is Roivant Sciences's cashless exercise of the company common stock warrants?
Roivant Sciences (ROIV) reported cashless exercise of the company common stock warrants of $0.00 in Q1 2026.
What does cashless exercise of the company common stock warrants mean?
The conversion of warrants into shares without any cash changing hands.